Journal article
Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections
DJ Handelsman, R Desai, AJ Conway, N Shankara-Narayana, BGA Stuckey, WJ Inder, M Grossmann, BB Yeap, D Jesudason, LP Ly, K Bracken, GA Wittert
European Journal of Endocrinology | Published : 2022
DOI: 10.1530/EJE-21-0608
Abstract
Context: The time course of male reproductive hormone recovery after stopping injectable testosterone undecanoate (TU) treatment is not known. Objective: The aim of this study was to investigate the rate, extent, and determinants of reproductive hormone recovery over 12 months after stopping TU injections. Materials and Methods: Men (n = 303) with glucose intolerance but without pathologic hypogonadism who completed a 2-year placebo (P)-controlled randomized clinical trial of TU treatment were recruited for further 12 months while remaining blinded to treatment. Sex steroids (testosterone (T), dihydrotestosterone, oestradiol, oestrone) by liquid chromatography-mass sprectometry, luteinizing ..
View full abstractGrants
Awarded by Bayer
Funding Acknowledgements
There was no funding for this study. The T4DM study was supported by grants from the National Health and Medical Research Council (NHMRC) Project Grant #1030123, Bayer, Lilly, and the University of Adelaide with in-kind support from Weight Watchers and Sonic Healthcare.